MML Investors Services’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-5,240
Closed -$282K – 2182
2022
Q3
$282K Buy
+5,240
New +$269K ﹤0.01% 1716
2022
Q1
– Sell
-2,586
Closed -$259K – 2087
2021
Q4
$259K Buy
2,586
+170
+7% +$17.6K ﹤0.01% 1775
2021
Q3
$302K Buy
2,416
+313
+15% +$37.2K ﹤0.01% 1642
2021
Q2
$261K Buy
2,103
+556
+36% +$74.8K ﹤0.01% 1684
2021
Q1
$236K Sell
1,547
-468
-23% -$70.7K ﹤0.01% 1639
2020
Q4
$260K Sell
2,015
-70
-3% -$8.05K ﹤0.01% 1465
2020
Q3
$233K Buy
+2,085
New +$191K ﹤0.01% 1414

Other funds holding GH

MML Investors Services's GH Position: Q4 2022 in Review

MML Investors Services sold out of Guardant Health (GH) in Q4 2022, closing a stake of 5,240 shares — an estimated $282K sold.

MML Investors Services first reported a position in GH in Q3 2020 and held it in 7 quarters. The position peaked at $302K in Q3 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • MML Investors Services reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • MML Investors Services sold 5,240 Guardant Health shares in Q4 2022, an estimated $282K.
  • MML Investors Services first reported a position in Guardant Health in Q3 2020 and held it in 7 quarters.
  • MML Investors Services's Guardant Health position peaked at $302K in Q3 2021.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on MML Investors Services's 13F filing for Q4 2022, filed 13 Feb 2023.